RSS
The AHRQ Question Builder App

The AHRQ Question Builder App

Helping patients and caregivers prepare for medical appointments and maximize visit time

7 December 2021
The AHRQ QuestionBuilder app helps patients and caregivers prepare for medical appointments and maximize visit time. Download the mobile app. Select or create questions to ask. Save the questions to a...
View More 
Macrophage Infection by HIV: Implications for...

Macrophage Infection by HIV: Implications for...

6 December 2021
Macrophage Infection by HIV: Implications for Pathogenesis and Cure: Day TwoThe National Institute of Mental Health (NIMH) and the Ragon Institute of MGH, MIT, and Harvard conducted a virtual meeting, Macrophage...
View More 
Macrophage Infection by HIV: Implications for...

Macrophage Infection by HIV: Implications for...

6 December 2021
Macrophage Infection by HIV: Implications for Pathogenesis and Cure: Day OneThe National Institute of Mental Health (NIMH) and the Ragon Institute of MGH, MIT, and Harvard conducted a virtual meeting, Macrophage...
View More 
Cyber Vitals: Information for Patients' Medical Device...

Cyber Vitals: Information for Patients' Medical Device...

Cybersecurity Awareness for Connected Medical Devices from the FDA

5 December 2021
As medical devices become more networked, they may become vulnerable to cybersecurity threats. Patients should preserve their personal information, monitor their device for strange symptoms or behaviors, and receive...
View More 

A Virtual Supermarket Program for the Screening of Mild...

3 December 2021
Background: Mild cognitive impairment (MCI) is often a precursor of dementia, and patients with MCI develop dementia at a higher rate than healthy older adults. Early detection of cognitive decline at the MCI stage supports better planning of care and interventions. At present, the use of virtual reality (VR) in screening for MCI in older adults is promising, but there is little evidence regarding the use of virtual supermarkets to screen for MCI. Objective: The objectives of this study are to validate a VR game–based test, namely, the Virtual Supermarket Program (VSP), for differentiating patients with MCI and healthy controls and to identify cutoff scores for different age levels. Methods: Subjects were recruited from several nursing homes and communities in Changchun, China. They were divided into a healthy control group (n=64) and an MCI group (n=62). All subjects were administered the VSP and a series of neuropsychological examinations. The study determined the optimal cutoff, discriminating validity, concurrent validity, and retest reliability of the VSP. We used the area under the receiver operating characteristic curve (AUC) to evaluate the discriminating validity and obtain the optimal cutoff values. Pearson correlation analysis and the intraclass correlation coefficient were used to evaluate the concurrent validity and retest reliability, respectively. Results: A cutoff score of 46.4 was optimal for the entire sample, yielding a sensitivity of 85.9% and specificity of 79.0% for differentiating individuals with MCI and healthy controls, and the AUC was 0.870 (95% CI 0.799-0.924). The median index of VSP score was 51.1 (range 42.6-60.0). There was a moderate positive correlation between the VSP total score and Mini-Mental State Examination score (r=0.429, P<.001). There was a strong positive correlation between VSP total score and Montreal Cognitive Assessment score (r=0.645, P<.001). The retest reliability of the VSP was feasible (r=0.588, P=.048). Conclusions: The VSP is interesting and feasible for subjects. It shows high sensitivity and specificity for the identification of MCI in older adults, which makes it a promising screening method. The VSP may be generalized to older adults in other countries, although some cultural adaptation may be necessary. Trial Registration: Chinese Clinical Trial Registry ChiCTR2000040074; https://www.chictr.org.cn/showprojen.aspx?proj=64639

This is the abstract only. Read the full text free (open access) on the JMIR Serious Games website. JMIR is the leading ehealth publisher: fast peer-review - open access - high impact.
First106107108109111113114115Last